The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


Research Projects

Project: Characterising monoclonal antibodies to malaria antigen VAR2CSA

Rogerson Group

VAR2CSA is the member of the Plasmodium falciparum Erythrocyte Membrane Protein 1 family of proteins that causes placental malaria. It is a target for malaria vaccines and therapeutics. We are isolating B cells from pregnant Papua New Guinean women that produce antibodies to VAR2CSA and characterising the functions and targets of these antibodies. You will work with some of these monoclonal antibodies to examine their targets and properties. This will include examining their binding to malaria infected red blood cells from different parasite strains, and how well they opsonise infected cells for uptake by cells including neutrophils and monocyte like cells. Techniques will include ELISAs and other plate based assays, malaria parasite culture, white blood cell isolation, flow cytometry and statistical analysis

Contact project supervisor for further
information and application enquiries

Project Supervisor

Professor Stephen Rogerson

Project Co-supervisor

Dr Elizabeth Aitken

Project availability
Master of Biomedical Science

Rogerson Group

3 vacancies

Bacterial and Parasitic Infections
Cross Cutting Disciplines
Discovery Research
Global Health
Clinical and health systems research

The Rogerson laboratory studies immunity to severe malaria in pregnant women and young children. We are identifying the targets and features of antibody responses that can protect against severe malaria in young children or against placental malaria. We have established assays to perform Systems Serology analyses of antibody immunity, including identification of the targets of antibody and the types of antibody response important for protection. These include antibody isotype and subclass, and engagement of Fc receptors and complement both in plate-based assays and using white blood cells, including neutrophils monocytes and NK cells. We are establishing assays of antibody glycosylation.

Rogerson Group Current Projects